Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (391-400 of 544) with videos related to

Pageof 55
Sort By:
JAMA Oncology|May 1, 2018
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation CarriersJoanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, et al.
Human Mutation|October 2, 2009
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variantLili Li, Kajal Biswas, Laura Anne Habib, et al.
Biomedicines|July 29, 2025
Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational ExposureKrzysztof Lubiński, Marcin R Lener, Wojciech Marciniak, et al.
International Journal of Molecular Sciences|July 12, 2025
Analysis of <i>GEN1</i> as a Breast Cancer Susceptibility Gene in Polish WomenKatarzyna Gliniewicz, Dominika Wokołorczyk, Wojciech Kluźniak, et al.
Breast Cancer Research and Treatment|February 6, 2013
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?Steven A Narod, Kelly Metcalfe, Henry T Lynch, et al.
International Journal of Cancer|October 31, 2009
CHEK2 mutations and HNPCC-related colorectal cancerJanina Suchy, Cezary Cybulski, Dominika Wokołorczyk, et al.
Gynecologic Oncology|May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.
Springerplus|July 18, 2015
Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysisJonathan Klein, Iwa Kong, Lawrence Paszat, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculatorsRobert K Nam, Michael W Kattan, Joseph L Chin, et al.
Pageof 55

Showing results (391-400 of 544) with videos related to

Sort By:
Pageof 55
JAMA Oncology|May 1, 2018
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation CarriersJoanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, et al.
Human Mutation|October 2, 2009
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variantLili Li, Kajal Biswas, Laura Anne Habib, et al.
Biomedicines|July 29, 2025
Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational ExposureKrzysztof Lubiński, Marcin R Lener, Wojciech Marciniak, et al.
International Journal of Molecular Sciences|July 12, 2025
Analysis of <i>GEN1</i> as a Breast Cancer Susceptibility Gene in Polish WomenKatarzyna Gliniewicz, Dominika Wokołorczyk, Wojciech Kluźniak, et al.
Breast Cancer Research and Treatment|February 6, 2013
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?Steven A Narod, Kelly Metcalfe, Henry T Lynch, et al.
International Journal of Cancer|October 31, 2009
CHEK2 mutations and HNPCC-related colorectal cancerJanina Suchy, Cezary Cybulski, Dominika Wokołorczyk, et al.
Gynecologic Oncology|May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.
Springerplus|July 18, 2015
Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysisJonathan Klein, Iwa Kong, Lawrence Paszat, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculatorsRobert K Nam, Michael W Kattan, Joseph L Chin, et al.
Pageof 55